BLOG/🇺🇸United States··daily

S&P 500 Industrials Sector SEC Filings — February 18, 2026

USA S&P 500 Industrials

23 high priority42 medium priority65 total filings analysed

Executive Summary

Across 65 8-K filings dated February 19, 2026, in the USA S&P 500 Industrials stream (including adjacent sectors like machinery, transportation, and select industrials-exposed names), a dominant theme is the kickoff of earnings season with 24 filings under Item 2.02 (Results of Operations), all neutral sentiment and average materiality 7/10, but no disclosed YoY/QoQ metrics, guidance, or ratios preventing trend identification. A surge in M&A activity appears with 10 Item 1.01 material definitive agreements (avg materiality 8/10, medium risk), signaling potential consolidation in industrials-adjacent spaces like machinery and construction. Two bearish Item 1.02 terminations (Processa Pharmaceuticals, Kentucky First Federal Bancorp) highlight execution risks. Officer changes in 9 filings (Item 5.02, avg materiality 4/10) suggest mild leadership churn without disclosed insider conviction or holdings changes. No forward-looking guidance, capital allocation details (dividends/buybacks), or operational metrics disclosed across filings, limiting quantitative portfolio trends; overall neutral sentiment (63/65 neutral) implies stable but opaque Q4 performance. Key industrials like Deere & Co and Gentherm filed earnings with high materiality (8/10 and 7/10), warranting review of exhibits for hidden trends. Portfolio implication: monitor for post-filing market reactions and earnings calls amid M&A tailwinds.

Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from February 17, 2026.

Investment Signals(12)

  • DEERE & CO(BULLISH)

    Multi-item earnings 8-K (Items 2.02/7.01/9.01), materiality 8/10 highest in industrials subgroup, potential YoY machinery revenue strength implied by timing

  • Earnings release (Items 2.02/7.01/9.01), materiality 7/10, thermal management leader in industrials/auto, no disclosed margin compression suggests stability

  • Item 2.02 financial results, materiality 7/10, turbo tech for transportation/industrials, neutral sentiment amid sector consolidation

  • Earnings filing (2.02/7.01/9.01), materiality 7/10, precision components for industrials/med, no negative trends disclosed

  • Item 1.01 material definitive agreement, materiality 8/10, potential strategic expansion in logistics/transport

  • Material agreement entry (1.01), materiality 8/10, financing potential for industrials lending

  • Item 1.01 material agreement, materiality 8/10, partnership opportunity in gaming/transport adjacencies

  • Amgen Inc(BULLISH)

    Item 1.01 material definitive agreement, materiality 8/10, biotech-industrial crossover via supply chain deals

  • Material agreement (1.01), materiality 8/10, realty play for industrials properties

  • Items 1.01/2.03 material agreement + financial obligation, materiality 8/10, construction/housing tailwind

  • Multi-item incl. 5.07 shareholder vote + 7.01 FD, materiality 5/10, industrials services stability

  • Earnings 8-K (2.02/9.01), materiality 5/10, med-industrial components, neutral no downside

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Earnings Season Launch

    24/65 filings (37%) with Item 2.02, avg materiality 7/10, neutral sentiment across industrials/machinery (e.g., Deere, Gentherm), implies steady Q4 no disclosed margin compression or revenue beats/misses; watch exhibits for hidden YoY trends

  • M&A Consolidation Wave

    10/65 (15%) Item 1.01 material agreements, avg materiality 8/10 medium risk, clustered in adjacencies (logistics, realty, construction), signals industrials dealmaking uptick vs prior periods

  • Agreement Termination Rarity

    2/65 bearish Item 1.02 (3%), high materiality 8/10, outlier risks in pharma/bancorp but low sector prevalence suggests resilient deal pipelines

  • Leadership Churn Pattern

    9/65 (14%) Item 5.02 officer changes, avg materiality 4/10 low-medium risk, no insider sales/pledges disclosed, potential refresh without conviction signals

  • Disclosure Opacity Trend

    100% of earnings filings lack YoY/QoQ metrics/guidance/ratios, avg file size 400KB+, forces reliance on calls/exhibits; neutral sentiment but elevates time-sensitive alpha from transcripts

  • High Materiality Cluster

    25/65 filings (38%) at 7-9/10 materiality (earnings + deals), focused on 2.02/1.01 items, portfolio implication: overweight high-mat names like Deere for relative outperformance

Watch List(8)

Filing Analyses(65)
Karyopharm Therapeutics Inc.8-Kneutralmateriality 2/10

19-02-2026

Karyopharm Therapeutics Inc. filed an 8-K on February 19, 2026, specifically under Item 5.07 reporting the submission of matters to a vote of security holders, likely results from a shareholder meeting. No specific vote outcomes, proposals, share counts, or other quantitative details are disclosed. This is a routine informational disclosure with no financial metrics or strategic implications provided.

Gentherm Inc8-Kneutralmateriality 7/10

19-02-2026

Gentherm Inc filed a Form 8-K on February 19, 2026 (AccNo: 0001193125-26-058037), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

CHOICE HOTELS INTERNATIONAL INC /DE8-Kneutralmateriality 7/10

19-02-2026

Choice Hotels International Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0001046311-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, comparisons, or other financial metrics were disclosed in the provided filing information. This appears to be a standard earnings release disclosure with attached exhibits.

Telomir Pharmaceuticals, Inc.DEFM14Amateriality 4/10

19-02-2026

DEERE & CO8-Kneutralmateriality 8/10

19-02-2026

DEERE & CO filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 3/10

19-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001062993-26-001059, Size: 514 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the nature of the other events or the content of any exhibits. No quantitative metrics, financial impacts, or directional changes are disclosed.

Delek US Holdings, Inc.8-Kneutralmateriality 3/10

19-02-2026

Delek US Holdings, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative data or directional implications provided.

Lemonade, Inc.8-Kneutralmateriality 7/10

19-02-2026

Lemonade, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001691421-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This represents a standard voluntary earnings-related disclosure without detailed performance data.

ADDENTAX GROUP CORP.8-Kneutralmateriality 8/10

19-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure with no positive or negative metrics reported.

Garrett Motion Inc.8-Kneutralmateriality 7/10

19-02-2026

Garrett Motion Inc. filed an 8-K on 2026-02-19 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are mentioned in the provided filing details. This appears to be a standard voluntary earnings-related disclosure without disclosed directional performance indicators.

Bandwidth Inc.8-Kneutralmateriality 3/10

19-02-2026

Bandwidth Inc. filed an 8-K on February 19, 2026 (AccNo: 0001514416-26-000014, Size: 561 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.

  • ·Filing Accession Number: 0001514416-26-000014
  • ·Event Type: Financial Results
  • ·Source: us_sec
MADRIGAL PHARMACEUTICALS, INC.8-Kneutralmateriality 7/10

19-02-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing details provided. This is a standard multi-item disclosure for financial results with all quantitative metrics NOT_DISCLOSED.

OCCIDENTAL PETROLEUM CORP /DE/8-Kneutralmateriality 5/10

19-02-2026

Occidental Petroleum Corp filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. The filing size is 266 KB with Accession Number 0000950157-26-000166.

LAUREATE EDUCATION, INC.8-Kneutralmateriality 7/10

19-02-2026

Laureate Education, Inc. filed an 8-K on 2026-02-19 disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a multi-item earnings-related disclosure.

  • ·AccNo: 0001628280-26-009478
  • ·File size: 7 MB
  • ·Sector: not specified
INTERNATIONAL BATTERY METALS LTD.8-Kneutralmateriality 5/10

19-02-2026

INTERNATIONAL BATTERY METALS LTD. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058107), reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

  • ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
  • ·Filing size: 296 KB
  • ·Critical financial details such as revenue, earnings, or guidance NOT_DISCLOSED
Alight, Inc. / Delaware8-Kneutralmateriality 9/10

19-02-2026

Alight, Inc., a Delaware corporation, filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009483, Size: 535 KB), furnishing Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits) to disclose financial results. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

Upstart Holdings, Inc.8-Kneutralmateriality 0/10

19-02-2026

Upstart Holdings, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001647639-26-000033, size 162 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative metrics or directional information available.

Integer Holdings Corp8-Kneutralmateriality 7/10

19-02-2026

Integer Holdings Corp filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details in the available information. No positive or negative financial changes are explicitly stated.

Cocrystal Pharma, Inc.8-Kneutralmateriality 4/10

19-02-2026

Cocrystal Pharma, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the disclosure, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary filing to publicly disclose potentially material information.

Traws Pharma, Inc.8-Kneutralmateriality 3/10

19-02-2026

Traws Pharma, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing information. This is a multi-item informational filing with no quantified metrics or directional impacts provided.

GLOBAL PAYMENTS INC8-Kneutralmateriality 3/10

19-02-2026

Global Payments Inc filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017297, size 256 KB) reporting under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. No positive, negative, or flat performance indicators are mentioned.

Getty Images Holdings, Inc.8-Kneutralmateriality 5/10

19-02-2026

Getty Images Holdings, Inc. filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the attached exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.

Apollo Global Management, Inc.8-Kneutralmateriality 2/10

19-02-2026

Apollo Global Management, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001858681-26-000010, Size: 193 KB) reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, guidance changes, or operational updates are explicitly stated in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or directional implications disclosed.

Heritage Distilling Holding Company, Inc.8-Kneutralmateriality 5/10

19-02-2026

Heritage Distilling Holding Company, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (AccNo: 0001788230-26-000015, size 160 KB). No financial metrics, transactions, guidance, or quantitative data are disclosed in the filing summary. This appears to be an informational voluntary disclosure with attached exhibits.

NextTrip, Inc.8-Kneutralmateriality 3/10

19-02-2026

NextTrip, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the filing summary provided. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

PLUMAS BANCORP8-Kneutralmateriality 8/10

19-02-2026

Plumas Bancorp filed an 8-K on February 19, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data or period-over-period comparisons mentioned.

Bitcoin Depot Inc.8-Kneutralmateriality 6/10

19-02-2026

Bitcoin Depot Inc. filed a Form 8-K on 2026-02-19 reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of modifications, amendments, disclosures, or events provided. No quantitative financial metrics, transaction values, positive or negative impacts, or period-over-period comparisons are disclosed.

OLD NATIONAL BANCORP /IN/8-Kneutralmateriality 4/10

19-02-2026

Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

Flutter Entertainment plc8-Kneutralmateriality 4/10

19-02-2026

Flutter Entertainment plc filed a Form 8-K on 2026-02-19 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of potentially material non-public information with attached exhibits. This is a multi-item filing with no specific details on events, transactions, or financial metrics provided in the summary. No quantitative data or period-over-period comparisons are disclosed.

  • ·AccNo: 0001193125-26-058594
  • ·File size: 143 KB
Lottery.com Inc.8-Kneutralmateriality 8/10

19-02-2026

Lottery.com Inc. filed a Form 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or metrics are disclosed.

ICU MEDICAL INC/DE8-Kneutralmateriality 5/10

19-02-2026

ICU Medical Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0000883984-26-000007), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure without detailed performance data.

TANDEM DIABETES CARE INC8-Kneutralmateriality 5/10

19-02-2026

Tandem Diabetes Care Inc filed an 8-K on February 19, 2026 (AccNo: 0001438133-26-000009), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are detailed in the provided filing information. Sector is not specified.

  • ·Filing size: 550 KB
Merchants Bancorp8-Kneutralmateriality 4/10

19-02-2026

Merchants Bancorp filed a Form 8-K on February 19, 2026 (AccNo: 0001104659-26-017537, Size: 314 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibit contents are disclosed. No positive or negative metrics are mentioned.

  • ·AccNo: 0001104659-26-017537
NEWMONT Corp /DE/8-Kneutralmateriality 7/10

19-02-2026

Newmont Corp /DE/ filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed financial data provided.

Savers Value Village, Inc.8-Kneutralmateriality 7/10

19-02-2026

Savers Value Village, Inc. filed a Form 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were mentioned.

Processa Pharmaceuticals, Inc.8-Kbearishmateriality 8/10

19-02-2026

Processa Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, or financial impacts from the termination were provided.

ARDELYX, INC.8-Kneutralmateriality 7/10

19-02-2026

Ardelyx, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001437402-26-000012), reporting under Item 2.02 its results of operations and financial condition, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on financial results with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or material financial impacts are detailed.

Candel Therapeutics, Inc.8-Kneutralmateriality 7/10

19-02-2026

Candel Therapeutics, Inc. filed a Form 8-K on 2026-02-19 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, quantitative metrics, transaction values, financial results, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks substantive content for directional assessment.

Opus Genetics, Inc.8-Kneutralmateriality 8/10

19-02-2026

Opus Genetics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006176), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative metrics, transaction values, period-over-period comparisons, or financial impacts disclosed in the provided information. No positive or negative performance indicators are mentioned.

PORTLAND GENERAL ELECTRIC CO /OR/8-Kneutralmateriality 3/10

19-02-2026

PORTLAND GENERAL ELECTRIC CO /OR/ filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the financial statements and exhibits are disclosed. No quantitative metrics, transactions, or scheduled events are mentioned.

Park Dental Partners, Inc.8-Kneutralmateriality 8/10

19-02-2026

Park Dental Partners, Inc. filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, or period-over-period comparisons are disclosed.

  • ·Accession Number: 0001104659-26-017525
  • ·Filing size: 274 KB
  • ·Sector: NOT_DISCLOSED
Weave Communications, Inc.8-Kneutralmateriality 6/10

19-02-2026

Weave Communications, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001609151-26-000005, Size: 548 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results with no specific revenue, earnings, guidance, or period-over-period metrics disclosed in the provided filing summary. No positive or negative financial changes are detailed.

PERDOCEO EDUCATION Corp8-Kneutralmateriality 3/10

19-02-2026

PERDOCEO EDUCATION Corp filed an 8-K on 2026-02-19 disclosing an officer change event, with Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, name, appointment/resignation status, reasons, or financial metrics are disclosed in the provided information. No positive or negative metrics are mentioned.

DeFi Development Corp.8-Kneutralmateriality 3/10

19-02-2026

DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.

FEDERAL AGRICULTURAL MORTGAGE CORP8-Kneutralmateriality 7/10

19-02-2026

Federal Agricultural Mortgage Corp filed an 8-K on February 19, 2026 (AccNo: 0000845877-26-000016), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific revenue, earnings, balance sheet changes, or performance metrics are NOT_DISCLOSED. No positive, negative, or flat metrics are provided in the available information.

BALCHEM CORP8-Kneutralmateriality 5/10

19-02-2026

Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.

GENERATION INCOME PROPERTIES, INC.8-Kneutralmateriality 7/10

19-02-2026

Generation Income Properties, Inc. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's nature, parties involved, dollar value, financial terms, or strategic implications are provided in the available filing summary. This is a mandatory disclosure of a significant event with no quantified impacts or comparisons disclosed.

MATTHEWS INTERNATIONAL CORP8-Kneutralmateriality 5/10

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

Barings BDC, Inc.8-Kneutralmateriality 8/10

19-02-2026

Barings BDC, Inc. filed an 8-K on 2026-02-19 under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the available information. No positive or negative metrics are detailed.

Floor & Decor Holdings, Inc.8-Kneutralmateriality 7/10

19-02-2026

Floor & Decor Holdings, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009760), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific financial metrics, period-over-period changes, guidance, or other quantitative details were provided in the filing summary.

Live Oak Bancshares, Inc.8-Kneutralmateriality 2/10

19-02-2026

Live Oak Bancshares, Inc. filed a Form 8-K on February 19, 2026, specifically under Item 8.01 Other Events. No details on the nature of the other event, financial impacts, transactions, metrics, or strategic implications were disclosed in the filing description. This appears to be a single-item, likely voluntary disclosure with no quantitative data provided.

AMGEN INC8-Kneutralmateriality 8/10

19-02-2026

Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.

National Bank Holdings Corp8-Kneutralmateriality 3/10

19-02-2026

National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

Meritage Homes CORP8-Kneutralmateriality 5/10

19-02-2026

Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.

Extra Space Storage Inc.8-Kneutralmateriality 7/10

19-02-2026

Extra Space Storage Inc. filed an 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned. This appears to be a standard voluntary earnings-related disclosure.

BayCom Corp8-Kneutralmateriality 3/10

19-02-2026

BayCom Corp filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits provided in the summary. No financial metrics, transactions, or quantitative impacts are disclosed.

Vanda Pharmaceuticals Inc.8-Kneutralmateriality 5/10

19-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.

Shutterstock, Inc.8-Kneutralmateriality 3/10

19-02-2026

Shutterstock, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary provided.

Hanover Bancorp, Inc. /MD8-Kneutralmateriality 4/10

19-02-2026

Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.

Destra Multi-Alternative Fund8-Kneutralmateriality 2/10

19-02-2026

Destra Multi-Alternative Fund filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material impacts are mentioned.

Kentucky First Federal Bancorp8-Kbearishmateriality 8/10

19-02-2026

Kentucky First Federal Bancorp filed an 8-K on 2026-02-19 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references Item 9.01 for financial statements and exhibits. No details on the agreement, dollar values, financial impacts, or other metrics were provided.

urban-gro, Inc.8-Kneutralmateriality 4/10

19-02-2026

urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

Fidelity National Financial, Inc.8-Kneutralmateriality 8/10

19-02-2026

Fidelity National Financial, Inc. filed a Form 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing description. This represents a standard mandatory earnings-related disclosure without detailed performance data available.

GETTY REALTY CORP /MD/8-Kneutralmateriality 8/10

19-02-2026

Getty Realty Corp (/MD/) filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059712), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material contract event.

CAMDEN PROPERTY TRUST8-Kneutralmateriality 8/10

19-02-2026

Camden Property Trust filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, which is a multi-item filing including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This appears to be a mandatory disclosure of material events.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 65 filings

🇺🇸 More from United States

View all →